uridine diphosphate glucuronic acid has been researched along with sipoglitazar in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asahi, S; Kawaguchi, N; Kiyota, Y; Kondo, T; Nishihara, M; Sudo, M; Takahashi, J | 1 |
1 other study(ies) available for uridine diphosphate glucuronic acid and sipoglitazar
Article | Year |
---|---|
An unusual metabolic pathway of sipoglitazar, a novel antidiabetic agent: cytochrome P450-catalyzed oxidation of sipoglitazar acyl glucuronide.
Topics: Alkylation; Animals; Aryl Hydrocarbon Hydroxylases; Biocatalysis; Cells, Cultured; Cytochrome P-450 CYP2C8; Dogs; Enzyme Inhibitors; Glucuronates; Glucuronides; Glucuronosyltransferase; Hepatocytes; Humans; Hypoglycemic Agents; Microsomes, Liver; Molecular Structure; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptors; Propionates; Recombinant Proteins; Substrate Specificity; Thiazoles; Uridine Diphosphate Glucuronic Acid | 2012 |